Bioprosthetics Market Analysis By Type (Allograft, Xenograft, Porcine, Bovine), By Application (Cardiovascular, Plastic Surgery & Wound Healing) And Segment Forecasts To 2024

Table of Contents

Chapter 1. Methodology and Scope
                       1.1. Research Methodology
                       1.2. Research Scope & Assumptions
                       1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
                       4.1. Market segmentation & scope
                       4.2. Market Driver Analysis
                       4.3. Market Restraint Analysis
                       4.4. Penetration & growth prospect mapping
                       4.5. Bioprosthetics-SWOT Analysis, By Factor (political & legal, economic and technological)
                       4.6. Industry Analysis - Porter's
Chapter 5. Market Categorization 1: Type Estimates & Trend Analysis
                       5.1. Bioprosthetics market: Type movement analysis
                       5.2. Allograft
                            5.2.1. Allograft Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                       5.3. Xenograft
                            5.3.1. Xenograft Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                            5.3.2. Porcine
                                    5.3.2.1. Porcine Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                            5.3.3. Bovine
                                    5.3.3.1. Bovine Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 6. Market Categorization 2: Application Estimates & Trend Analysis
                       6.1. Bioprosthetics market: Application movement analysis
                       6.2. Cardiovascular
                            6.2.1. Cardiovascular Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                       6.3. Plastic surgery & wound healing
                            6.3.1. Plastic surgery & wound healing Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                            6.3.2. Porcine
                                    6.3.2.1. Porcine Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                            6.3.3. Bovine
                                    6.3.3.1. Bovine Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 7. Market Categorization 3: Regional Estimates & Trend Analysis, By Type & Application
                       7.1. Bioprosthetics Market Share By Region, 2015 & 2024
                       7.2. North America
                            7.2.1. North America Market Estimates and Forecasts, By Type, 2013 - 2024 (USD Million)
                                    7.2.1.1. U.S. Market Estimates and Forecasts
                                    7.2.1.2. Canada Market Estimates and Forecasts
                            7.2.2. North America Market Estimates and Forecasts, By Application, 2013 - 2024 (USD Million)
                                    7.2.2.1. U.S. Market Estimates and Forecasts
                                    7.2.2.2. Canada Market Estimates and Forecasts
                       7.3. Europe
                            7.3.1. Europe Market Estimates and Forecasts, By Type, 2013 - 2024 (USD Million)
                                    7.3.1.1. UK Market Estimates and Forecasts
                                    7.3.1.2. Germany Market Estimates and Forecasts
                            7.3.2. Europe Market Estimates and Forecasts, By Application, 2013 - 2024 (USD Million)
                                    7.3.2.1. UK Market Estimates and Forecasts
                                    7.3.2.2. Germany Market Estimates and Forecasts
                       7.4. Asia Pacific
                            7.4.1. Asia Pacific Market Estimates and Forecasts, By Type, 2013 - 2024 (USD Million)
                                    7.4.1.1. Japan Market Estimates and Forecasts
                                    7.4.1.2. China Market Estimates and Forecasts
                                    7.4.1.3. India Market Estimates and Forecasts
                            7.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2013 - 2024 (USD Million)
                                    7.4.2.1. Japan Market Estimates and Forecasts
                                    7.4.2.2. China Market Estimates and Forecasts
                                    7.4.2.3. India Market Estimates and Forecasts
                       7.5. Latin America
                            7.5.1. Latin America Market Estimates and Forecasts, By Type, 2013 - 2024 (USD Million)
                                    7.5.1.1. Brazil Market Estimates and Forecasts
                                    7.5.1.2. Mexico Market Estimates and Forecasts
                            7.5.2. Latin America Market Estimates and Forecasts, By Application, 2013 - 2024 (USD Million)
                                    7.5.2.1. Brazil Market Estimates and Forecasts
                                    7.5.2.2. Mexico Market Estimates and Forecasts
                       7.6. MEA
                            7.6.1. MEA Market Estimates and Forecasts, By Type, 2013 - 2024 (USD Million)
                                    7.6.1.1. South Africa Market Estimates and Forecasts
                            7.6.2. MEA Market Estimates and Forecasts, By Application, 2013 - 2024 (USD Million)
                                    7.6.2.1. South Africa Market Estimates and Forecasts
Chapter 8. Competitive Landscape
                       8.1. Strategy framework
                       8.2. Market participation categorization
                       8.3. Company Profiles
                            8.3.1. LeMaitre Vascular, Inc.
                                    8.3.1.1. Company Overview
                                    8.3.1.2. Financial Performance
                                    8.3.1.3. Product Benchmarking
                                    8.3.1.4. Strategic Initiatives
                            8.3.2. Braile Biomedica, Inc.
                                    8.3.2.1. Company Overview
                                    8.3.2.2. Financial Performance
                                    8.3.2.3. Product Benchmarking
                                    8.3.2.4. Strategic Initiatives
                            8.3.3. Labcor Laboratorios Ltd.
                                    8.3.3.1. Company Overview
                                    8.3.3.2. Financial Performance
                                    8.3.3.3. Product Benchmarking
                                    8.3.3.4. Strategic Initiatives
                            8.3.4. Maquet Metinge Group
                                    8.3.4.1. Company Overview
                                    8.3.4.2. Financial Performance
                                    8.3.4.3. Product Benchmarking
                                    8.3.4.4. Strategic Initiatives
                            8.3.5. Medtronic Plc.
                                    8.3.5.1. Company Overview
                                    8.3.5.2. Financial Performance
                                    8.3.5.3. Product Benchmarking
                                    8.3.5.4. Strategic Initiatives
                            8.3.6. Aortech International Plc
                                    8.3.6.1. Company Overview
                                    8.3.6.2. Financial Performance
                                    8.3.6.3. Product Benchmarking
                                    8.3.6.4. Strategic Initiatives
                            8.3.7. CryoLife, Inc.
                                    8.3.7.1. Company Overview
                                    8.3.7.2. Financial Performance
                                    8.3.7.3. Product Benchmarking
                                    8.3.7.4. Strategic Initiatives
                            8.3.8. Sorin Group
                                    8.3.8.1. Company Overview
                                    8.3.8.2. Financial Performance
                                    8.3.8.3. Product Benchmarking
                                    8.3.8.4. Strategic Initiatives
                            8.3.9. Humacyte, Inc.
                                    8.3.9.1. Company Overview
                                    8.3.9.2. Financial Performance
                                    8.3.9.3. Product Benchmarking
                                    8.3.9.4. Strategic Initiatives
                            8.3.10. Ethicon, Inc.
                                    8.3.10.1. Company Overview
                                    8.3.10.2. Financial Performance
                                    8.3.10.3. Product Benchmarking
                                    8.3.10.4. Strategic Initiatives
                            8.3.11. LifeCell International
                                    8.3.11.1. Company Overview
                                    8.3.11.2. Financial Performance
                                    8.3.11.3. Product Benchmarking
                                    8.3.11.4. Strategic Initiatives
                            8.3.12. Organogenesis, Inc.
                                    8.3.12.1. Company Overview
                                    8.3.12.2. Financial Performance
                                    8.3.12.3. Product Benchmarking
                                    8.3.12.4. Strategic Initiatives
                            8.3.13. St. Jude Medical, Inc.
                                    8.3.13.1. Company Overview
                                    8.3.13.2. Financial Performance
                                    8.3.13.3. Product Benchmarking
                                    8.3.13.4. Strategic Initiatives
                            8.3.14. Edwards Lifesciences Corporation
                                    8.3.14.1. Company Overview
                                    8.3.14.2. Financial Performance
                                    8.3.14.3. Product Benchmarking
                                    8.3.14.4. Strategic Initiatives
                            8.3.15. JenaValve Technology GmbH
                                    8.3.15.1. Company Overview
                                    8.3.15.2. Financial Performance
                                    8.3.15.3. Product Benchmarking
                                    8.3.15.4. Strategic Initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 3 North America xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 4 North America bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 5 U.S. bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 6 U.S. xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 7 U.S. bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 8 Canada bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 9 Canada xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 10 Canada bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 11 Europe bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 12 Europe xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 13 Europe bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 14 Germany bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 15 Germany xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 16 Germany bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 17 UK bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 18 UK xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 19 UK bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 20 Asia Pacific bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 21 Asia Pacific xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 22 Asia Pacific bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 23 Japan bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 24 Japan xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 25 Japan bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 26 China bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 27 China xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 28 China bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 29 India bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 30 India xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 31 India bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 32 Latin America bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 33 Latin America xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 34 Latin America bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 35 Brazil bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 36 Brazil xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 37 Brazil bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 38 Mexico bioprosthetics market, by type, 2013 - 2024 (USD Million)
TABLE 39 Mexico xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 40 Mexico bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 41 MEA bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 42 MEA xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 43 MEA bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 44 South Africa bioprosthetics market, by application, 2013 - 2024 (USD Million)
TABLE 45 South Africa xenograft market, by type, 2013 - 2024 (USD Million)
TABLE 46 South Africa bioprosthetics market, by application, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Bioprosthetics market type outlook key takeaways
FIG. 10 Bioprosthetics market: Type movement analysis
FIG. 11 Global allograft market, 2013 - 2024 (USD Million)
FIG. 12 Global xenograft market, 2013 - 2024 (USD Million)
FIG. 13 Global porcine market, 2013 - 2024 (USD Million)
FIG. 14 Global bovine market, 2013 - 2024 (USD Million)
FIG. 15 Bioprosthetics market application outlook key takeaways
FIG. 16 Bioprosthetics market: Application movement analysis
FIG. 17 Global cardiovascular market, 2013 - 2024 (USD Million)
FIG. 18 Global plastic surgery & wound healing market, 2013 - 2024 (USD Million)
FIG. 19 Regional market place: Key takeaways
FIG. 20 Regional outlook, 2015 & 2022
FIG. 21 North America bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 22 U.S. bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 23 Canada bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 24 Europe bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 25 Germany bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 26 UK bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 27 Asia Pacific Bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 28 Japan bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 29 China bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 30 India bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 31 Latin America bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 32 Brazil bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 33 Mexico bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 34 MEA bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 35 South Africa bioprosthetics market, 2013 - 2024 (USD Million)
FIG. 36 Strategy framework
FIG. 37 Participant categorization